United Kingdom
GBEurope
Regulatory Overview
United Kingdom is regulated by the MHRA (Medicines and Healthcare products Regulatory Agency). The country has 3 documented regulatory pathways for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.
Regulatory Authority
MHRA (Medicines and Healthcare products Regulatory Agency)
Regulatory Pathways (3)
MHRA scheme giving patients with life-threatening or seriously debilitating conditions access to pre-approval medicines. Companies can obtain a Promising Innovative Medicine (PIM) designation and then an EAMS Scientific Opinion.
UK physicians can prescribe unlicensed medicines for named patients under their personal responsibility. The prescriber takes responsibility for the decision and monitors the patient.
EAMS gives patients with life-threatening or seriously debilitating conditions access to medicines that don't yet have a marketing authorisation.
Drugs Available (245)
| ISO Code | GB |
| Region | Europe |
| Regulatory Authority | MHRA (Medicines and Healthcare products Regulatory Agency) |
| Pathways | 3 documented |
| Drugs Available | 245 drug(s) |